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The clinical suspicion of myocarditis relies strongly on 
endomyocardial biopsy for confirmation, yet the sensitivity 
of the procedure in this setting has not been clearly defined. 
Biopsy sensitivity was determined in 14 hearts with histo- 
logically proved myocarditis studied ex vivo, including 12 
autopsy hearts and 2 native hearts explanted at cardiac 
transplantation. With use of the Stanford and Cordis 
bioptomes, endoymocardial biopsy was performed near the 
apex on the right side of the ventricular septum (four to five 
samples/bioptome per patient) and repeated in the nonapi- 
cal portion of the septum from the moderator band to the 
subpulmonary infundibulum (additional three to five sam- 
pleslbioptome per patient). 
In a casewise assessment, 43% to 57% of the endomyo- 
cardial samples were diagnostic for myocarditis, as calcu- 
lated separately for each bioptome in each region of sam- 
pling (apicalinonapical). Both apical and nonapical 
sensitivity improved to 64% when the findings of the two 
bioptomes were combined (eight to nine samples/patient in 
each region). By collectively analyzing all available samples 
for each patient, 11 (79%) of 14 cases could be diagnosed, 
but this required a mean of 17.2 samples/patient, a number 
clinically unrealistic. The exclusion of four cases of fungal 
myocarditis from analysis did not significantly alter the 
results. In transmural ventricular sections, none of four 
patients with sudden death had inflammatory disease con- 
fined to the conduction system. 
In conclusion, despite six to eight negative biopsy sam- 
ples/patient with suspected myocarditis, repeat biopsy may 
still be warranted. 
(.I Am Co11 Cardiol1989;14:915-20) 
The transvenous endomyocardial biopsy is essential to the 
current diagnostic evaluation of myocarditis. However, 
early concerns regarding the utility of the biopsy in cardio- 
myopathy and other forms of heart disease (i j recurred a 
decade later in the context of unexplained heart failure and 
myocarditis (2). Despite quantitative (3) and qualitative (4) 
criteria and the illustrated use of endomyocardial biopsies in 
myocarditis (5,6), challenges remain in understanding the 
role of lymphocytes in cardiomyopathic disease (7) and in 
the evaluation of mononuclear cells in heart tissue (8,9). The 
degree of interobserver variability (IO) has been addressed 
by the widely accepted histopathologic working criteria for 
myocarditis (4). The issue of natural variability of myo- 
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carditic infiltrates and the potential for biopsy sampling error 
have not been resolved. 
The residual uncertainty of a negative biopsy finding was 
tested by Spiegelhalter and Stovin (I I) in cardiac allograft 
rejection. By constructing a statistical model, these investi- 
gators determined that three negative specimens would be 
sufficient if a 5% chance of a mild rejection was acceptable 
evidence not to alter therapy, whereas four negative samples 
would reduce the error rate to 2%. By plotting the incremen- 
tal improvement in the sensitivity for moderate rejection in 
autopsy-acquired samples, Zerbe and Arena (12) demon- 
strated a plateau in the sensitivity at values of 90% to 93% 
when six or more samples were obtained. Baandrup et al. 
(13) found a minimum of five biopsy specimens necessary to 
reliably establish the structural relations on the cellular 
diameters and the volume fractions of collagen and the 
interstitium in the heart. More recently, the preliminary data 
of Hauck et al. (14) showed that despite IO biopsy samples/ 
ventricle in each of 38 cases of lymphocytic myocarditis, the 
frequency of false negative results was 37% for the right 
ventricle and 45% for the left ventricle. 
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Table 1. Right Ventricular Endomyocardial Biopsy in 14 Cases of Myocarditis 
Histologic Category 




No. of Samples* 
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5 0) 3 5 3 
5 4 4 5 
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*Biopsy samples were obtained at apical and nonapical septal sites using two bioptomes (CA = Cordis bioptome, apical; CN = Cordis bioptome, nonapical; 
SA = Stanford bioptome, apical; SN = Stanford bioptome. nonapical). The number of positive samples is indicated in parentheses. thlyocarditis: 0 = none; ? 
= borderline; t = mild; t t = moderate; t t t = severe. SThe heart in Cases 5 and IO was a native organ explanted at cardiac transplantation. §Based on at 
least one positive sample/patient (EmbiPt), with 17.2 samples/patient (mean). F = female: M = male. 
The processes of allograft rejection, myocarditis, fibrosis the Cordis disposable bioptome (5.4F, catalog no. 502-302). 
and hypertrophy are distinct enough in nature and extent Both devices are clinically employed in the cardiac cathe- 
that their respective evaluation by endomyocardial biopsy terization laboratory for transvenous endomyocardial biopsy 
may be differentially successful. To further define biopsy by the internal jugular approach. The Cordis bioptome (1.84 
sensitivity in myocarditis, we sampled the right side of the mm3 sample volume) provides tissue fragments approxi- 
ventricular septum in 14 patients with histologically proved mately one-third the volume of those provided by the 
myocarditis, accommodating for differences in the size and Stanford bioptome. This difference permitted an evaluation 
location of the samples. of the influence of sample size on diagnosis. 
Methods 
Study patients (Table 1). Fourteen patients with myo- 
carditis were studied (seven male and seven female, ranging 
in age from 1 to 70 years [mean 40.91). Twelve of the patients 
died, and two others required cardiac transplantation for 
treatment. Six patients presented initially with heart failure 
or shock, four with sudden death and four with systemic 
fungal infection complicating other medical conditions. The 
heart was studied ex vivo, either at autopsy or during 
orthotopic allograft placement. Histologic evaluation of mul- 
tiple transmural slices of the ventricular myocardium re- 
vealed mixed mononuclear cell (n = 6), granulomatous (n = 
2), giant cell (n = l), rheumatic (n = 1) and fungal (n = 4) 
myocarditis in these patients. 
Catheter bioptomes. Two adult bioptomes were used: the 
Stanford bioptome (9F, Scholten Surgical Instruments) and 
Sampling strategy. Apical endomyocardial samples were 
obtained from the right side of the ventricular septum. Each 
bioptome was advanced across the tricuspid valve from the 
direction of the superior vena cava, and sample location was 
verified by inspection. The right ventricular cavity was then 
opened, and paired specimens were taken by the adjacent 
placement of each bioptome in the nonapical septum at 
multiple locations evenly distributed from the moderator 
band to the subpulmonary infundibulum. 
Evaluation of myocarditis. After staining with hematoxy- 
lin-eosin (12 stepped levels) and with Masson’s trichrome (4 
levels), each biopsy sample was histologically evaluated for 
myocarditis according to the Dallas criteria (4). The severity 
of disease and the character of the cellular infiltrate, if 
present, were documented. For comparison, full-thickness 
ventricular slices from all patients were sectioned, stained 
and similarly examined for the maximal severity of disease 
and the character of the cellular infiltrate. 
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Observer variability. Each endomyocardial sample was 
interpreted on two separate occasions by a certified pathol- 
ogist (B.M.M.) familiar with the Dallas criteria (4) and 
unaware of all clinical data and autopsy or explant findings, 
yielding an intraobserver correlation coefficient of 0.86 
(Spearman rank correlation). Independent assessment on a 
separate occasion by a second certified cardiovascular pa- 
thologist (S.J.R.) yielded correlation coefficients of 0.80 and 








By the Case I 
6Ot 
Biopsy sensitivity. Positive biopsy samples were those 
showing definite myocarditis; samples with borderline myo- 
carditis were considered separately, as designated in the 
Results section. Diagnostic sensitivity “by the specimen” 
expressed the likelihood of a positive diagnosis in an indi- 
vidual biopsy sample; sensitivity “by the case” reflected the 
frequency of at least one positive sample in a patient, 
analogous to the typical evaluation of multiple samples from 
a single patient. In casewise analysis, the sensitivity was 
considered first for each bioptome in each region of sampling 
(apicalinonapical). then for the results pooled between the 
bioptomes in the respective regions and lastly by combining 
all the available samples in each patient. 
SA CA SN CN SA CA SN CN SA SN All 
C’A CTi 
Specimens/Case = 4.9 3.d4.0 4.Y a.4 a.8 1Z2 
Results 
Endomyocardial samples. The number of biopsy samples 
available in each case is listed in Table 1. On average (i 
SD), 4.9 2 0.5 and 4.8 t 0.4 samples/patient were obtained 
with the Stanford bioptome from the apical and nonapical 
septum, respectively. With the Cordis bioptome. the corre- 
sponding figures were 3.8 i 0.9 and 4.3 I- 0.8 samples/ 
patient, respectively, excluding one infant in whom no 
sample was available with this bioptome. In total. there were 
17.2 f 3.3 biopsy specimens for each patient. 
Figure 1. Diagnostic sensitivity of right ventricular endomyocardial 
biopsy. The sensitivity of a single biopsy specimen (A) and the 
sensltlvity of samples assessed by the case (B) are shown. The latter 
represents the frequency of at least one positive sample in each 
patient. Data are separated by the region of sampling and the 
bioptome used. *Excludes one infant case for which no sample was 
available with this bioptome (Cordis). CA = Cordis bioptome, 
apical: CN = Cordis bioptome, nonapical: SA = Stanford bioptome, 
apical; SN = Stanford bioptome, nonapical. 
Diagnostic sensitivity (Fig. 1). On the basis of the fre- 
quency of positive biopsy samples in Table 1. the diagnostic 
sensitivity was calculated for each bioptome in each region 
of sampling. For individual biopsy samples. the sensitivity 
ranged from 22.1% to 28.0%, without a significant difference 
between the apical and the nonapical samples or between the 
Stanford and the Cordis bioptomes (p = 0.90 by chi-square 
analysis, 3 degrees of freedom, raw frequency data). Fifty- 
five specific comparisons of nonapical samples obtained with 
the two bioptomes from immediately adjacent sites gave an 
identical sensitivity of 23.6% for each bioptome. Notably. 
however, only 10 of the I3 diagnostic samples from one 
bioptome had a paired sample that was also positive by the 
other bioptome. 
57.1%. without a significant difference between the two 
bioptomes or between apical and nonapical sites of sampling 
(p = 0.95 by chi-square analysis, 3 degrees of freedom, 
raw frequency data). In the apical septum, where samples 
from the two bioptomes were not paired, each bioptome 
yielded diagnostic findings for myocarditis in six cases, with 
both bioptomes giving positive results in three of these 
cases. 
On the basis of multiple samples from each patient, the 
casewise analysis of sensitivity was performed to more 
accurately reflect clinical practice. such that a minimum of 
one clearly abnormal sample would be sufficient for diagno- 
sis (Fig. 1). The casewise sensitivity ranged from 42.9% to 
In the absence of a significant difference between the 
sampling sensitivity of the two bioptomes, the endomyocar- 
dial samples were pooled to give an average of 8.4 and 8.8 
specimens/patient in the apical and nonapical septum, re- 
spectively. In this way, the casewise sensitivity reached 
64.3% for the apical and the nonapical samples alike (Fig. 1). 
Furthermore. because there was no significant difference in 
the diagnostic sensitivity between the apical and the nonapi- 
cal samples, all available specimens in each patient were 
analyzed collectively. With this procedure, myocarditis 
could be diagnosed in 11 of the 14 cases, which is equal to a 
sensitivity of 78.6%. but at a mean (2 SD) requirement of 
17.2 + 3.3 samples/patient, which is clearly unattainable in 
clinical practice. 
Borderline myocarditis. By the Dallas criteria (4), a bi- 
opsy sample showing equivocal histologic findings for myo- 
carditis is termed borderline and may indicate the need for 
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repeat biopsy in patients in whom a strong clinical suspicion 
of myocarditis remains. When samples histologically border- 
line for myocarditis were included for calculation in this 
study, the sensitivity of an individual sample increased to 
33.2%, whereas the casewise sensitivity improved to 62.8% 
in the absence of pooling between bioptomes or septal 
regions and to 85.7% with all the samples pooled in each 
patient. 
Discussion 
Fungal myocarditis. Although fungal infections second- 
arily involving the myocardium would not normally rely on 
endomyocardial biopsy for evaluation, analysis of our data 
after excluding cases of fungal myocarditis produced virtu- 
ally no change in results, with increased biopsy sensitivity 
limited to 1% to 6% at each level of comparison (by the 
specimen or by the case, with or without pooling between 
bioptomes or locations of sampling). 
Limited biopsy sensitivity. Biopsy sampling of the right 
ventricular endomyocardium from the ventricular septum of 
14 patients with histologically confirmed myocarditis dem- 
onstrated relatively low levels of diagnostic sensitivity. With 
four to five samples/patient, the chance of a successful 
diagnosis was near 50%. Although 11 of 14 cases could be 
diagnosed after the cumulative pooling of samples, an aver- 
age of >17 samples/case was required. The statistical eval- 
uation by Spiegelhalter and Stovin (11) gave a considerably 
more optimistic outlook in the setting of cardiac allograft 
rejection; the latter has been substantiated by the empirical 
data of others (12,15) and by our own experience in a 
separate study of biopsy sampling in failed human heart 
allografts (unpublished data). 
Sudden death. Myocarditis manifested as sudden death 
may represent a subset of the disease that differs histologi- 
cally from myocarditis causing heart failure. The spectrum 
of severity of myocarditis by full autopsy or explant exam- 
ination was similar in cases of heart failure and sudden death 
in this study (Table I), and biopsy sensitivity assessed for 
each bioptome in each region of sampling and for each level 
of pooling showed no statistically significant difference in 
patients with sudden death versus those with heart failure (p 
= 0.20 by Mann-Whitney U test). Moreover, transmural 
sections of the ventricular septum, obtained specifically at 
sites sampled by biopsy, confirmed the presence of myo- 
carditis in the vicinity of biopsy in all four patients with 
sudden death, and excluded disease isolated to the conduc- 
tion system in these patients. 
In a recent abstract, Hauck et al. (14) presented their 
findings of endomyocardial sampling with the Cordis biop- 
tome in 38 autopsy hearts with lymphocytic myocarditis. 
They found myocarditis in only 66 (17%) of 380 biopsy 
samples from the right ventricle and 76 (20%) of 380 samples 
from the left ventricle. Furthermore, with 10 biopsy samples/ 
ventricle per patient, their casewise sensitivity was 63% for 
the right ventricle and 55% for the left. Thus, there is a 
concordance of contemporary but fully independent obser- 
vations from their laboratory and ours, which strongly 
emphasizes the significance of the results. 
Severity of myocarditis. The maximal severity of disease 
is shown in Table 1 for all patients. On the basis of histologic 
assessment of random transmural ventricular sections, two 
patients had severe, seven had moderate and five had mild 
myocarditis. In contrast, the grade of myocarditis observed 
in the biopsy samples was generally less, with eight patients 
judged to have mild disease. One of the latter (Patient 7) 
presented with sudden death and had severe granulomatous 
myocarditis in transmural sections (Fig. 2A and B); 18 of the 
19 biopsy specimens in this patient were negative for myo- 
carditis, and the single sample judged mildly positive is 
shown in Figure 2C and D. Three patients without myocardi- 
tis by biopsy had moderate disease on full histologic exam- 
ination. 
Histologic subsets. Besides purely lymphocytic myo- 
carditis, eosinophilic, giant cell and other forms of inflam- 
matory infiltrates are included within the working (Dallas) 
criteria for the diagnosis of myocarditis (4). Although at 
times granulomatous and giant cell myocarditis are a mani- 
festation of known systemic conditions, they are frequently 
idiopathic. Moreover, the clinician presented with suspected 
myocarditis cannot justifiably discriminate among histologic 
subsets. Rheumatic myocarditis without significant valvular 
involvement may be first recognized only after histologic 
examination after cardiac allograft replacement (unpublished 
observations). Accordingly, in the present study we endeav- 
ored to include myocarditis of different origins. In this 
respect, cases of fungal myocarditis, although not ordinarily 
assessed by endomyocardial biopsy, did not influence the 
overall results when they were excluded from analysis. 
These observations suggest that there is an inherent limita- 
tion of current bioptome approaches that is more important 
in determining biopsy sensitivity than the uniqueness of a 
given histologic subset of myocarditis. 
Infiltrate morphology. The infiltrating cell types were Sudden death. Patients with sudden death may present 
poorly represented in the endomyocardial biopsy samples. for endomyocardial biopsy when successfully resuscitated 
Among the cases positive for myocarditis by biopsy, one (16). That the heart in patients with sudden death in our 
granulomatous, one rheumatic and two fungal cases could study clearly had disease present within the “working” 
not be subclassified accordingly. The histologic impression ventricular septal myocardium suggests that isolated fortu- 
on biopsy was generally one of mixed mononuclear cell itous involvement of the conduction system does not char- 
infiltration. acterize such patients and may not account for their death. 
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Sample volume. From our study, it appeared that the 
focal nature of the myocarditic lesions negated any advan- 
tage of a larger sample obtainable with the Stanford biop- 
tome because the Stanford and the Cordis bioptomes 
showed virtually identical sensitivity. Nevertheless, the re- 
sults with the two bioptomes differed significantly in individ- 
ual cases, a finding that served only to illustrate the unpre- 
dictable distribution of the myocarditic lesions. 
Sample location. Altering the site of endomyocardial 
sampling away from the customary location in the right 
ventricular apical septum did not improve diagnostic sensi- 
tivity. The nonapical septal samples in our study and the left 
ventricular samples in the study by Hauck et al. (14) did not 
produce superior results. 
Figure 2. Patient 7. Histologic assessment of transmural ventricular 
section versus endomyocardial biopsy sample. This 40 year old 
woman died suddenly and was found to have severe granulomatous 
myocarditis in transmural ventricular sections obtained at postmor- 
tem examination (a). The subendocardial area outlined in a is shown 
under higher power in b, demonstrating an admixture of typical 
lymphocytes, histiocytoid forms and possible giant cells and an 
appearance of interstitial edema. An irreversibly damaged, hyper- 
eosinophilic and partially vacuolated cardiomyocyte is indicated by 
the arrows. From a total of 19 endomyocardial biopsy samples 
obtained ex vivo in this patient, only 1 sample was judged positive 
on the basis of a single focus of mild disease shown entirely in c and 
under higher power in d. Hematoxylin-eosin stain; original magni- 
fication xl25 in a and c and x330 and b and d. 
Newer histologic methods. The use of immunohisto- myocardial biopsy samples of various diagnostic categories 
chemic markers for lymphocytes and other infiltrating cell (17) showed that the leukocyte count in myocarditis, despite 
types in transmural myocardial specimens has improved the having a significantly higher mean value, overlapped consid- 
detection and quantitation of these cells (8,9). What role erably with those of the other patient groups. Nonetheless, a 
such techniques have in the evaluation of biopsy samples in role for this technique in borderline cases of myocarditis was 
myocarditis requires more study. Immunoperoxidase stain- advocated as a complement to conventional staining. More 
ing for leukocyte common antigen in 199 consecutive endo- specific monoclonal reagents to whole populations or sub- 
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diagnostic sensitivity, however, cannot be expected without 
sets of lymphocytes or to muscle-specific actin, including 
many additional markers effective in formalin-fixed, paraf- 
fin-embedded tissues in myocarditis (18) remain to be tested 
in endomyocardial biopsy samples. 
A prospective study (19) of 79 patients with myocarditis 
or dilated cardiomyopathy demonstrated a strong associa- 
tion between immunofluorescent staining for immunoglobu- 
lin and complement deposits and the presence of inflamma- 
tory infiltration in endomyocardial biopsy material. A gain in 
3. Edwards WD, Holmes DR Jr, Reeder GS. Diagnosis of active lympho- 
Med 1983;308:12-8. 
cytic myocarditis by endomyocardial biopsy: quantitative criteria for light 
microscopy. Mayo Clin Proc 1982;57:419-25. 
4. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histo- 
pathologic definition and classification. Am J Cardiovasc Path01 1986; 
1:3-14. 
5. Mason JW, Billingham ME, Ricci DR. Treatment of acute inflammatory 
myocarditis assisted by endomyocardial biopsy. Am J Cardiol 1980; 
45: 1037-44. 
6. Fenoglio JJ Jr, Ursell PC, Kellogg CF, Drusin RE, Weiss MB. Diagnosis 
and classification of myocarditis by endomyocardial biopsy. N Engl J 
a revision of the current criteria to include immunofluores- 
cence data. In the same study, electron microscopy of the 
biopsy samples gave valuable prognostic information, but 
did not predict myocarditis. 
Prospectus. Despite apparently limited sensitivity, the 
endomyocardial biopsy has essential value in cases of sus- 
pected myocarditis because diagnostic confirmation is oth- 
erwise difficult. In this regard, the Dallas Criteria (4) remain 
the working standard for the histopathologic diagnosis of 
myocarditis, and these criteria applied by a pathology panel 
(of which B.M.M. is a member) form the foundation of 
patient entry into an ongoing National Institutes of Health- 
sponsored multicenter Myocarditis Treatment Trial. The 
objectivity of pathologists interpreting endomyocardial bi- 
opsy specimens is unaffected by the caveat of biopsy sensi- 
tivity discussed in this report. As well, detection of myo- 
carditis may be achieved by timely biopsy in many living 
patients suspected of having myocarditis with the number of 
tissue samples currently obtained in the clinical setting. We 
do believe that an important challenge lies in improving 
current diagnostic methods through novel means of sampling 
or further refinements in the approach to histologic assess- 
ment. On the basis of our findings and those of others 
(14), we recommend that repeat biopsy be considered in 
patients strongly suspected to have myocarditis in order to 
increase the number of tissue samples available for his- 
tologic analysis. 
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